Refractory ITP
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP (NCT05613296) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2023-05-05 |
Track Refractory ITP automatically
Every clearance here is in the API, with alerts when new ones post.